These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6151483)

  • 21. Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial.
    Haywood LJ
    Am Heart J; 1984 Sep; 108(3 Pt 2):787-93. PubMed ID: 6148005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group.
    Eur Heart J; 1988 Jan; 9(1):8-16. PubMed ID: 2894312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of propranolol in postinfarction patients with mechanical or electrical complications.
    Furberg CD; Hawkins CM; Lichstein E
    Circulation; 1984 Apr; 69(4):761-5. PubMed ID: 6365352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias.
    Morganroth J; Lichstein E; Byington R
    Prev Med; 1985 May; 14(3):346-57. PubMed ID: 3903736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta blockers in ischemic heart disease.
    Wilhelmsson C; Vedin A
    Am J Cardiol; 1983 Jul; 52(2):108A-112A. PubMed ID: 6135344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of beta-adrenergic blocking agents after myocardial infarction.
    Frishman WH; Ruggio J; Furberg C
    Postgrad Med; 1985 Dec; 78(8):40-6, 49-53. PubMed ID: 2866506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience.
    Furberg CD; Byington RP
    Circulation; 1983 Jun; 67(6 Pt 2):I98-101. PubMed ID: 6133654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group.
    Peters RW; Byington RP; Barker A; Yusuf S
    J Clin Epidemiol; 1990; 43(2):167-72. PubMed ID: 2406377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period.
    Hjalmarson A
    Am J Cardiol; 1997 Nov; 80(9B):35J-39J. PubMed ID: 9375948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of electrocardiographic persistent ST depression in patients with their first myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial.
    Gheorghiade M; Shivkumar K; Schultz L; Jafri S; Tilley B; Goldstein S
    Am Heart J; 1993 Aug; 126(2):271-8. PubMed ID: 8337995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The beta-blocker heart attack trial.
    Furberg C
    Br J Clin Pharmacol; 1982; 14 Suppl 1(Suppl 1):3S-5S. PubMed ID: 6126206
    [No Abstract]   [Full Text] [Related]  

  • 32. The Beta-blocker Heart Attack Trial.
    Furberg CD
    Z Kardiol; 1985; 74 Suppl 6():159-63. PubMed ID: 2869615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural history of the first non-Q wave myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial.
    Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S
    Am Heart J; 1991 Dec; 122(6):1548-53. PubMed ID: 1957749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.
    Kjekshus JK
    Am J Cardiol; 1986 Apr; 57(12):43F-49F. PubMed ID: 2871745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of visit adherence in the national beta-blocker heart attack trial.
    Bell RL; Curb JD; Friedman LM; McIntyre KM; Payton-Ross C
    Control Clin Trials; 1985 Jun; 6(2):89-101. PubMed ID: 3891227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long term propranolol treatment and changes in body weight after myocardial infarction.
    Rössner S; Taylor CL; Byington RP; Furberg CD
    BMJ; 1990 Apr; 300(6729):902-3. PubMed ID: 2186832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of propranolol in reducing mortality in older myocardial infarction patients. The Beta-Blocker Heart Attack Trial experience.
    Hawkins CM; Richardson DW; Vokonas PS
    Circulation; 1983 Jun; 67(6 Pt 2):I94-7. PubMed ID: 6342843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Beta-Blocker Therapy after Myocardial Infarction in the Reperfusion Era: A Systematic Review.
    Hong J; Barry AR
    Pharmacotherapy; 2018 May; 38(5):546-554. PubMed ID: 29601115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship of treatment adherence to the risk of death after myocardial infarction in women.
    Gallagher EJ; Viscoli CM; Horwitz RI
    JAMA; 1993 Aug; 270(6):742-4. PubMed ID: 8336377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of Propranolol in Resistant Arterial hypertension Treatment (APROPRIATE study): study protocol for a randomized double-blind placebo-controlled trial.
    Constantine GR; Ranasinghe P; Weeratunga P; Weeraratne C; Galappatthy P; Rajapakse S; Senarath U; Katulanda P
    Trials; 2017 Mar; 18(1):124. PubMed ID: 28292320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.